 AUSTIN, Texas, Nov. 04, 2022 GLOBE NEWSWIRE -- Molecular Templates, Inc. Nasdaq: MTEM, Molecular Templates, or MTEM, a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies ETBs, today announced that it will present four abstracts and host an in-person Research Development Day, Friday, November 11, 2022, at The Society for Immunotherapy of Cancers SITC 37th Annual Meeting which will be held November 8 12, 2022 at the Boston Convention and Exhibition Center in Boston, MA. 